Akasu T, Kakizoe T
Department of Surgery, National Cancer Center Hospital, Tokyo, Japan.
Nihon Geka Gakkai Zasshi. 1998 Jun;99(6):385-90.
Experimental animal studies have demonstrated a protective effect of NSAIDs against intestinal tumorigenesis due to chemical carcinogens. Many epidemiological studies have also shown that regular aspirin use is associated with reduction of the risk of colorectal cancer. In familial adenomatous polyposis, numerous clinical studies have reported that sulindac and indomethacin are effective in reducing colorectal polyps. However, their effects are incomplete and they may cause severe toxicity. Therefore, they are unlikely to replace colectomy as primary treatment. Nevertheless, their unique effects on colorectal tumorigenesis warrant further basic and clinical research on NSAIDs, including COX-2-selective inhibitors.
实验动物研究已证明非甾体抗炎药对化学致癌物所致肠道肿瘤发生具有保护作用。许多流行病学研究也表明,经常使用阿司匹林与降低结直肠癌风险相关。在家族性腺瘤性息肉病中,大量临床研究报告称舒林酸和吲哚美辛对减少结直肠息肉有效。然而,它们的效果并不完全,且可能会引起严重毒性。因此,它们不太可能替代结肠切除术作为主要治疗方法。尽管如此,它们对结直肠肿瘤发生的独特作用值得对非甾体抗炎药,包括COX-2选择性抑制剂,进行进一步的基础和临床研究。